HR 7479 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To require the Secretary of Labor to issue guidance and regulations regarding opioid overdose reversal medication and employee training.
Summary
The Workplace Overdose Reversal Kits to Save Lives Act (WORK to Save Lives Act) would require the Department of Labor to issue guidance and regulations regarding opioid overdose reversal medication in the workplace. The bill directs OSHA to issue non-mandatory guidance to private employers on acquiring and maintaining opioid overdose reversal medication and providing annual voluntary training to employees on its use. The bill also mandates that OSHA issue regulations requiring federal agencies to acquire and maintain such medication and offer annual voluntary training to their employees. These requirements apply to most federal agencies, including the Veterans Health Administration. The guidance and regulations must be issued within 270 days of the bill's enactment.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
15 cosponsors
- Del. Norton, Eleanor Holmes [D-DC-At Large] (D-DC)
- Rep. Amo, Gabe [D-RI-1] (D-RI)
- Rep. Budzinski, Nikki [D-IL-13] (D-IL)
- Rep. Carson, André [D-IN-7] (D-IN)
- Rep. Cohen, Steve [D-TN-9] (D-TN)
- Rep. Craig, Angie [D-MN-2] (D-MN)
- Rep. Davis, Danny K. [D-IL-7] (D-IL)
- Rep. Goldman, Daniel S. [D-NY-10] (D-NY)
- Rep. Grijalva, Adelita S. [D-AZ-7] (D-AZ)
- Rep. Jackson, Jonathan L. [D-IL-1] (D-IL)
- Rep. McClain Delaney, April [D-MD-6] (D-MD)
- Rep. McIver, LaMonica [D-NJ-10] (D-NJ)
- Rep. Rutherford, John H. [R-FL-5] (R-FL)
- Rep. Thanedar, Shri [D-MI-13] (D-MI)
- Rep. Tlaib, Rashida [D-MI-12] (D-MI)
Money behind the sponsor
Top reported contributors to Bonnie Watson Coleman’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- BEIGENE $13,400
- PRINCETON UNIVERSITY $11,150
- WINNING STRATEGIES WASHINGTON $8,600
- NEW JERSEY DEPT. OF HEALTH $7,600
- GHO VENTURES, LLC $7,600
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Bonnie Watson Coleman → · Outside spending →
Actions (2)
- Feb 10, 2026 Referred to the House Committee on Education and Workforce. · house
- Feb 10, 2026 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Full text
IN THE HOUSE OF REPRESENTATIVES
February 10, 2026
Mrs. Watson Coleman (for herself, Mr. Rutherford, Ms. Tlaib, Mrs. McIver, Ms. Craig, Ms. Budzinski, Mr. Amo, Mr. Davis of Illinois, Mr. Thanedar, Mr. Goldman of New York, Mrs. McClain Delaney, Mr. Carson, Ms. Norton, and Mrs. Grijalva) introduced the following bill; which was referred to the Committee on Education and Workforce
A BILL
To require the Secretary of Labor to issue guidance and regulations regarding opioid overdose reversal medication and employee training.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Workplace Overdose Reversal Kits to Save Lives Act” or the “WORK to Save Lives Act”.
SEC. 2. NON-MANDATORY GUIDANCE FOR EMPLOYERS CONCERNING OPIOID OVERDOSE REVERSAL MEDICATION.
(a) In General.—Not later than 270 days after the date of enactment of this Act, the Secretary of Labor, acting through the Occupational Safety and Health Administration, shall issue nonmandatory guidance to employers on—
(1) acquiring and maintaining opioid overdose reversal medication; and
(2) offering voluntary training to employees on an annual basis on the usage of such medication.
(b) Employer Defined.—In this section, the term “employer” has the meaning given such term in section 3 of the Occupational Safety and Health Act of 1970 (29 U.S.C. 652), except that such term does not include the United States Postal Service.
SEC. 3. MANDATORY REGULATIONS FOR FEDERAL AGENCIES CONCERNING OPIOID OVERDOSE REVERSAL MEDICATION.
(a) In General.—Not later than 270 days after the date of enactment of this Act, the Secretary of Labor, acting through the Occupational Safety and Health Administration, shall issue regulations to require each Federal agency to—
(1) acquire and maintain opioid overdose reversal medication; and
(2) offering voluntary training to employees on an annual basis on the usage of such medication.
(b) Federal Agency Defined.—In this section, the term “Federal agency” means any agency or instrumentality of the Federal Government, including the Veterans Health Administration, notwithstanding section 7425(b) of title 38, United States Code. <all>
Comments